Key Points

Kiri Industries has posted a significant net loss of Rs 85 crore for Q4 FY25, a steep rise from the previous year's loss. Revenue also decreased by 6.5% to Rs 205 crore. However, the company brought some positive news by announcing the sale of its 37.57% stake in DyStar to Zhejiang Longsheng Group. The deal, valued at $676.26 million, exceeds Kiri's current market capitalisation and could be a game-changer pending regulatory approvals.

Key Points: Kiri Industries Reports Q4 Net Loss and DyStar Stake Sale

  • Kiri Industries reports a Rs 85 crore loss in Q4 FY25
  • Revenue falls by 6.5% to Rs 205 crore
  • Announces sale of its 37.57% stake in DyStar
  • Sale value surpasses Kiri's market cap, subject to approvals
2 min read

Kiri Industries' net loss widens to Rs 85 crore in Q4, revenue drops

Kiri Industries' Q4 loss soars to Rs 85 crore while announcing DyStar stake sale.

"The sale could provide a major cash boost to Kiri Industries. - Company Statement"

Mumbai, June 1

Kiri Industries Limited, a dye and chemical maker, has announced that the company posted a net loss of Rs 84.6 crore during the quarter (Q4 FY25), which is much higher than the Rs 9.6 crore loss it reported in the same period previous fiscal (Q4 FY24).

Revenue also declined by 6.5 per cent, falling to Rs 205 crore in the last quarter of FY25 from Rs 219.3 crore a year ago, according to its stock exchange filing.

Despite the disappointing earnings, the company made a major announcement along with the financial results.

Kiri Industries has signed a Share Purchase Agreement (SPA) with Zhejiang Longsheng Group to sell its entire 37.57 per cent stake in DyStar, a global dyes and chemicals company.

The base sale price is $676.26 million, which is roughly Rs 5,765 crore at current exchange rates.

This deal is notable because the sale value is much higher than Kiri Industries’ current market capitalisation, which stands at about Rs 3,800 crore.

As part of the agreement, Zhejiang Longsheng Group will acquire 26.23 lakh equity shares held by Kiri Industries in DyStar.

In addition to the base amount, Kiri Industries may also receive an extra $20.29 million.

This would be paid if there is any shortfall in the base amount or if the buyer needs to fulfil other responsibilities under the agreement.

However, the final amount could still change depending on certain conditions, the company said in its regulatory filing.

The deal is still subject to regulatory approvals and other closing formalities. Once completed, this sale could provide a major cash boost to Kiri Industries and help reshape its business direction.

Meanwhile, shares of Kiri Industries dropped 9.43 per cent on Friday to Rs 658 on the Bombay Stock Exchange (BSE).

Kiri Industries Limited (KIL) is an Indian company engaged in the manufacturing and export of dyes, dye intermediates, and basic chemicals.

As a fully integrated dyes and chemicals producer, KIL operates a wide range of facilities. The company is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

- IANS

Share this article:

Reader Comments

R
Rahul K.
The DyStar stake sale seems like a smart exit strategy. Getting nearly ₹5,765 crore when your market cap is ₹3,800 crore is brilliant! Hope they use this cash injection wisely to turn around their core business. Indian chemical sector needs strong players.
P
Priya M.
Worrying financials but the silver lining is definitely the stake sale. The Chinese buyer paying premium shows our Indian companies have valuable assets. Hope SEBI scrutinizes this deal properly though - we've seen many such deals favoring foreign companies in past.
S
Sanjay T.
Loss widening from ₹9.6 cr to ₹84.6 cr is shocking! Management needs to explain what went wrong. Selling stake is good but what's the long term vision? Just becoming a cash-rich company without growth plans won't help shareholders. #TransparencyNeeded
A
Ananya R.
As someone from Gujarat where Kiri has plants, I hope this deal brings stability. Many jobs depend on this company. The 9% stock drop seems like knee-jerk reaction - fundamentals might improve post this deal. Fingers crossed! 🤞
V
Vikram J.
Chemical sector is cyclical but Kiri's performance is concerning. They should use sale proceeds to invest in R&D - Chinese companies are ahead in specialty chemicals. Time to focus on high-margin products rather than commodity dyes.
N
Neha P.
Mixed feelings about this. On one hand, great valuation for stake sale. On other hand, why are we letting another strategic asset go to Chinese company? Hope there are strict conditions on technology transfer and IP protection. Make in India should work both ways!

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50